Premium
Intraventricular apolipoprotein ApoJ infusion acts protectively in Traumatic Brain Injury
Author(s) -
Huang Zhijian,
Cheng Chongjie,
Jiang Li,
Yu Zhanyang,
Cao Fang,
Zhong Jianjun,
Guo Zongduo,
Sun Xiaochuan
Publication year - 2016
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/jnc.13491
Subject(s) - traumatic brain injury , neuroprotection , medicine , evans blue , blood–brain barrier , extravasation , anesthesia , inflammation , pathology , central nervous system , psychiatry
Traumatic brain injury ( TBI ) is the leading cause of mortality and morbidity in youth, but to date, effective therapies are still lacking. Previous studies revealed a marked response of apolipoprotein J (ApoJ) expression to the brain injury. The aim of this study was to determine the potential roles of ApoJ in functional recovery following TBI . After controlled cortex impact ( CCI ), a TBI model, in adult wild‐type mice, ApoJ expression was up‐regulated since 6 h post‐injury and sustained for 5 days. Animals infused with recombinant human ApoJ intraventricularly at 30 min prior to CCI showed significantly reduced oxidative stress (3‐nitrotyrosine, 4‐hydroxynonenal) and complement activation (C5b‐9). In addition, ApoJ treatment was shown to suppress the inflammatory response (glial activation, cytokine expression), blood–brain barrier disruption (Evans blue extravasation), and cerebral edema (water content) induced by CCI . Concomitantly, improved neuronal maintenance and neurological behavioral performance were observed in ApoJ‐treated mice compared with the vehicle group. These findings support a neuroprotective role of ApoJ via multifunctional pathways, providing a novel and encouraging treatment strategy for TBI .Apolipoprotein J (ApoJ) was up‐regulated after controlled cortical impact ( CCI ). Mice infused with human recombinant ApoJ prior to CCI showed reduced expression of complement and oxidative marker proteins as well as reduced inflammatory response and attenuated blood–brain barrier ( BBB ) disruption and cerebral edema. Neuronal maintenance and behavioral performance were improved by ApoJ infusion. These findings demonstrated the protective function of ApoJ for traumatic brain injury ( TBI ) therapy.